• Dimetridazole: Advanced Protocols for Antimicrobial and Sens

  2026-06-11

  Dimetridazole stands apart as both a potent antimicrobial and a precision tool for electrochemical sensing, uniquely enabling high-sensitivity detection workflows and multidrug-resistance research. Discover stepwise protocol enhancements, troubleshooting strategies, and the scientific breakthrough that redefines residue monitoring and microbial pathogenesis studies.

• A40926: Dalbavancin Precursor Redefining Antibacterial Assay

  2026-06-10

  A40926 stands out as a potent dalbavancin precursor, enabling high-sensitivity in vitro antibacterial assays and robust research on multidrug-resistant pathogens. Its unique efficacy profile and well-characterized mechanism make it indispensable for Gram-positive infection and Neisseria gonorrhoeae inhibition workflows.

• Jiedu Xiaozheng Yin Modulates Macrophage Polarization via TL

  2026-06-10

  Liu et al. demonstrate that Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine, inhibits colitis-associated colorectal cancer progression by promoting macrophage polarization towards the M1 phenotype through TLR4 pathway activation. This study provides mechanistic insight into immune microenvironment modulation as a promising strategy for colorectal cancer intervention.

• Distinct Apoptosis Pathways in BMECs Induced by Candida krus

  2026-06-09

  This study elucidates how the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) via separate molecular mechanisms. These insights provide a mechanistic basis for targeted intervention in mycotic mastitis and highlight the value of pathway-specific apoptosis assays.

• RSL3 Glutathione Peroxidase 4 Inhibitor: Protocols and Innov

  2026-06-09

  Explore how (1S,3R)-RSL3, a benchmark glutathione peroxidase 4 inhibitor, is revolutionizing ferroptosis research and cancer biology workflows. This guide details experimental enhancements, troubleshooting insights, and cutting-edge findings from the latest literature to empower your oxidative stress and tumor inhibition studies.

• Detection of HHV-7 DNA in Ocular Toxoplasmosis: Diagnostic I

  2026-06-08

  This case report documents the first detection of human herpesvirus 7 (HHV-7) DNA in the vitreous humor of a patient with ocular toxoplasmosis, implicating viral reactivation as a possible factor in refractory uveitis. The findings highlight the need for comprehensive molecular diagnostics in persistent infectious uveitis and inform future antimicrobial resistance research in ophthalmology.

• DAPT (GSI-IX) in Notch Pathway Research: Applied Protocols &

  2026-06-08

  DAPT (GSI-IX) is a benchmark γ-secretase inhibitor, enabling precise modulation of Notch signaling and amyloid precursor protein processing. Explore validated workflows, experimental advantages, and troubleshooting strategies for neurodegeneration, cancer, and stem cell research—grounded in both cutting-edge literature and real-world use cases.

• HPF: Precision hROS Detection and Protocol Optimization in C

  2026-06-07

  Discover how HPF (hydroxyphenyl fluorescein) transforms highly reactive oxygen species detection with unmatched specificity. This in-depth analysis integrates latest research and practical assay guidance for advanced oxidative stress visualization.

• PD 0332991 (Palbociclib) HCl: CDK4/6 Inhibition in Cancer Re

  2026-06-06

  PD 0332991 (Palbociclib) HCl is a potent, selective CDK4/6 inhibitor that induces G1 phase cell cycle arrest in Rb-positive tumor cells. Its efficacy is demonstrated by low-nanomolar IC50 values and robust antiproliferative activity in both in vitro and in vivo models. This article details the molecular rationale, benchmarks, practical workflow guidance, and limitations relevant to researchers employing this agent in cancer studies.

• CX-5461: Revolutionizing Cancer Research via RNA Polymerase

  2026-06-05

  CX-5461, a targeted RNA polymerase I inhibitor, is transforming translational cancer research by disrupting ribosomal RNA synthesis and selectively inducing senescence and autophagy in solid tumor models. This article provides mechanistic insight, evidence-based experimental guidance, and strategic context for harnessing CX-5461—offered by APExBIO—in the evolving landscape of cancer therapeutics, with a special focus on overcoming chemoresistance and enhancing clinical relevance.

• A40926: A Novel Glycopeptide with Anti-Neisseria Activity

  2026-06-05

  This study introduces A40926, a glycopeptide antibiotic complex with unique and potent activity against both Gram-positive bacteria and Neisseria gonorrhoeae. The research details the compound’s isolation, structural features, and notable efficacy, positioning A40926 as an important tool for antibiotic development and resistant pathogen research.

• GKT137831: Redefining Redox Modulation in Translational Rese

  2026-06-04

  Explore how GKT137831, a potent dual NADPH oxidase Nox1/Nox4 inhibitor, empowers translational researchers to dissect and modulate oxidative stress across vascular, hepatic, and metabolic disease models. This article bridges mechanistic insight, experimental best practices, and a forward-looking perspective on advancing redox biology and therapeutic innovation.

• Technical Guide: YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-y

  2026-06-04

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is used to study inhibition of hypoxia-inducible factor 1 transcriptional activity and tumor angiogenesis in cancer biology research workflows. It is not suitable for diagnostic or medical applications, and its use is limited to scientific research contexts requiring robust HIF-1α inhibition and soluble guanylyl cyclase activation.

• Regulatory Cross-Talk in A40926 and Teicoplanin Biosynthesis

  2026-06-03

  This study uncovers nuanced interactions between pathway-specific regulators (PSRs) in the biosynthesis of glycopeptide antibiotics A40926 and teicoplanin. By dissecting the interchangeability and specificity of regulatory genes, the work advances understanding of antibiotic production control and suggests new strategies for optimizing yields of key dalbavancin precursors.

• LAMP1 Modulates CXCL10-CXCR3 Axis in Macrophage Polarization

  2026-06-03

  This study reveals how LAMP1 regulates the CXCL10-CXCR3 axis to influence macrophage polarization states during inflammation. The findings highlight the context-dependent actions of CXCR3 signaling and demonstrate that AMG 487, a CXCR3 antagonist, can shift macrophage phenotypes and ameliorate acute lung injury in a murine model.

451 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page